BG105997A - Method of controlling weight gain associated with therapeutic drugs - Google Patents

Method of controlling weight gain associated with therapeutic drugs

Info

Publication number
BG105997A
BG105997A BG105997A BG10599701A BG105997A BG 105997 A BG105997 A BG 105997A BG 105997 A BG105997 A BG 105997A BG 10599701 A BG10599701 A BG 10599701A BG 105997 A BG105997 A BG 105997A
Authority
BG
Bulgaria
Prior art keywords
weight gain
gain associated
therapeutic drugs
controlling weight
certain
Prior art date
Application number
BG105997A
Other languages
Bulgarian (bg)
English (en)
Inventor
Carl Mendel
Timothy SEATON
Steve Weinstein
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of BG105997A publication Critical patent/BG105997A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG105997A 1999-03-19 2001-10-10 Method of controlling weight gain associated with therapeutic drugs BG105997A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12534099P 1999-03-19 1999-03-19
PCT/US2000/007130 WO2000056313A1 (en) 1999-03-19 2000-03-17 Method of controlling weight gain associated with therapeutic drugs

Publications (1)

Publication Number Publication Date
BG105997A true BG105997A (en) 2002-06-28

Family

ID=22419292

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105997A BG105997A (en) 1999-03-19 2001-10-10 Method of controlling weight gain associated with therapeutic drugs

Country Status (20)

Country Link
US (1) US6376552B1 (de)
EP (1) EP1162965A1 (de)
JP (1) JP2002539251A (de)
KR (1) KR20020000784A (de)
CN (1) CN1353603A (de)
AU (1) AU3757800A (de)
BG (1) BG105997A (de)
BR (1) BR0009159A (de)
CA (1) CA2367021A1 (de)
CZ (1) CZ291864B6 (de)
HU (1) HUP0200393A2 (de)
IL (1) IL145241A0 (de)
MX (1) MXPA01009467A (de)
NO (1) NO20014480L (de)
NZ (1) NZ514009A (de)
PL (1) PL350919A1 (de)
SK (1) SK13352001A3 (de)
TR (1) TR200102695T2 (de)
WO (1) WO2000056313A1 (de)
ZA (1) ZA200107692B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002019998A2 (en) * 2000-09-08 2002-03-14 Eli Lilly And Company A method of treating weight gain associated with atypical antipsychotic use
BR0315084A (pt) * 2002-10-05 2005-08-16 Hanmi Pharm Ind Co Ltd Composição farmacêutica compreendendo hemiidrato cristalino de metanossulfonato de sibutramina
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
US20060035827A1 (en) * 2004-06-24 2006-02-16 Green Gary M Compositions and methods for the treatment or prevention of gallbladder disease
KR20060080818A (ko) 2005-01-06 2006-07-11 씨제이 주식회사 시부트라민의 술폰산염
KR20060080817A (ko) 2005-01-06 2006-07-11 씨제이 주식회사 시부트라민의 디카복실산염
JP2008526836A (ja) * 2005-01-06 2008-07-24 シージェー チェイルジェダン コーポレーション シブトラミンの無機酸塩
KR20060093564A (ko) * 2005-02-22 2006-08-25 종근당바이오 주식회사 무수 시부트라민 말산염 및 이의 제조 방법
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
JP2010503709A (ja) * 2006-09-15 2010-02-04 レビバ ファーマシューティカルズ，インコーポレーテッド シクロアルキルメチルアミンの合成、使用方法および組成物
BRPI0716002A2 (pt) * 2006-11-22 2013-07-30 Sk Chemicals Co Ltd complexo de inclusço, processo de preparaÇço de um complexo de inclusço e composiÇço de tratamento e prevenÇço de hipocondria e obesidade

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
CA2367021A1 (en) 2000-09-28
WO2000056313A1 (en) 2000-09-28
IL145241A0 (en) 2002-06-30
ZA200107692B (en) 2002-12-18
PL350919A1 (en) 2003-02-10
AU3757800A (en) 2000-10-09
CZ291864B6 (cs) 2003-06-18
JP2002539251A (ja) 2002-11-19
SK13352001A3 (sk) 2002-03-05
MXPA01009467A (es) 2004-03-19
KR20020000784A (ko) 2002-01-05
EP1162965A1 (de) 2001-12-19
TR200102695T2 (tr) 2002-01-21
CN1353603A (zh) 2002-06-12
NZ514009A (en) 2001-09-28
NO20014480D0 (no) 2001-09-14
NO20014480L (no) 2001-11-02
BR0009159A (pt) 2001-12-26
HUP0200393A2 (en) 2002-08-28
US6376552B1 (en) 2002-04-23
CZ20013283A3 (cs) 2002-07-17

Similar Documents

Publication Publication Date Title
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
GB2254784B (en) Film-coated solid dosage form of anti-migraine drug
ATE410506T1 (de) Behandlung der pompeschen krankheit
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
NO20022014L (no) En fast oral kontrollert frigjorende doseringsform inneholdende hydrokodon
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
FI935847A0 (fi) L-DOPA-esterkompositioner
RU2003135482A (ru) Геропротектор на основе гидрированных пиридо(4,3-b) индолов (варианты), фармакологическое средство на его основе и способ его применения
BG105997A (en) Method of controlling weight gain associated with therapeutic drugs
MXPA02001571A (es) Metodo de tratamiento para el cancer.
GB9727131D0 (en) Therapeutic agents
EP1228758A4 (de) Prohylaktische und therapeutische mittel für entzündliche darmerkrankungen
BG103278A (en) Medicamentous treatment
GB9108629D0 (en) Heterocyclic pharmaceutical compounds,preparation and use
HK1006284A1 (en) Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use
MY113062A (en) Amide derivatives and their therapeutic use
CA2438509A1 (en) Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria
BG106180A (en) Pharmaceutical composition containing sibutramine and orlistat
KR910018348A (ko) 술포닐아미노치환 비시클로환계 히드록삼산 유도체
BG106209A (en) Therapeutic agents
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
RU2005102923A (ru) Средство от диабета
MY133438A (en) Morpholinobenzamide salts
MXPA01009468A (es) Tratamiento de hipertension pulmonar.
DE60026559D1 (de) Arzneimittel gegen essstörungen